• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $EYE

    National Vision Holdings Inc.

    Subscribe to $EYE
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

    IPO Year: 2017

    Exchange: NASDAQ

    Website: nationalvision.com

    Recent Analyst Ratings for National Vision Holdings Inc.

    DatePrice TargetRatingAnalyst
    7/30/2025$36.00Buy
    Roth Capital
    7/8/2025$30.00Equal Weight → Overweight
    Barclays
    5/9/2025$21.00Neutral → Buy
    Citigroup
    5/7/2025Underperform → Buy
    BofA Securities
    10/17/2023$25.00 → $16.00Buy → Neutral
    Goldman
    7/27/2023$28.00 → $22.00Buy → Neutral
    Citigroup
    7/27/2023$30.00 → $21.00Overweight → Equal Weight
    Wells Fargo
    5/2/2023Overweight → Equal Weight
    Barclays
    3/31/2023$23.00Hold → Buy
    Loop Capital
    1/17/2023Overweight → Equal-Weight
    Morgan Stanley
    See more ratings

    National Vision Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Wilkes Alexander

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    8/4/25 4:32:18 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    President, America's Best Banner Mark converted options into 11,728 shares and covered exercise/tax liability with 3,462 shares (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    7/9/25 4:21:56 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Zulla Caitlin was granted 10,870 units of Restricted Stock Units, increasing direct ownership by 99% to 21,880 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:40:50 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Ofarrell Susan C was granted 9,674 shares, increasing direct ownership by 76% to 22,333 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:39:21 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Nicholson Michael J was granted 7,392 units of Restricted Stock Units, increasing direct ownership by 222% to 10,719 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:38:28 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Mcgrann James M. was granted 7,392 units of Restricted Stock Units, increasing direct ownership by 222% to 10,719 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:37:19 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Kelman Naomi was granted 7,392 shares, increasing direct ownership by 22% to 41,041 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:35:34 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Johnson Susan S was granted 7,392 shares, increasing direct ownership by 20% to 43,700 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:33:54 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Hepner Virginia A was granted 7,392 shares, increasing direct ownership by 20% to 44,027 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:32:17 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Armario Jose was granted 10,870 shares, increasing direct ownership by 28% to 49,901 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    6/23/25 4:31:16 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Peeler D Randolph bought $264,200 worth of shares (25,000 units at $10.57) (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    8/14/24 4:27:52 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Director Hepner Virginia A bought $10,365 worth of shares (1,000 units at $10.37), increasing direct ownership by 3% to 36,635 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    8/14/24 4:26:51 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Fahs L Reade bought $299,200 worth of shares (20,000 units at $14.96), increasing direct ownership by 3% to 633,097 units (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    5/14/24 8:01:46 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Peeler D Randolph bought $491,198 worth of shares (34,000 units at $14.45) (SEC Form 4)

    4 - National Vision Holdings, Inc. (0001710155) (Issuer)

    5/14/24 8:00:26 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on National Vision with a new price target

    Roth Capital initiated coverage of National Vision with a rating of Buy and set a new price target of $36.00

    7/30/25 7:33:08 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision upgraded by Barclays with a new price target

    Barclays upgraded National Vision from Equal Weight to Overweight and set a new price target of $30.00

    7/8/25 8:23:14 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision upgraded by Citigroup with a new price target

    Citigroup upgraded National Vision from Neutral to Buy and set a new price target of $21.00

    5/9/25 8:39:42 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision upgraded by BofA Securities

    BofA Securities upgraded National Vision from Underperform to Buy

    5/7/25 2:46:43 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision downgraded by Goldman with a new price target

    Goldman downgraded National Vision from Buy to Neutral and set a new price target of $16.00 from $25.00 previously

    10/17/23 7:19:16 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision downgraded by Citigroup with a new price target

    Citigroup downgraded National Vision from Buy to Neutral and set a new price target of $22.00 from $28.00 previously

    7/27/23 8:59:58 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded National Vision from Overweight to Equal Weight and set a new price target of $21.00 from $30.00 previously

    7/27/23 6:12:47 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision downgraded by Barclays

    Barclays downgraded National Vision from Overweight to Equal Weight

    5/2/23 8:57:10 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision upgraded by Loop Capital with a new price target

    Loop Capital upgraded National Vision from Hold to Buy and set a new price target of $23.00

    3/31/23 8:58:26 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision downgraded by Morgan Stanley

    Morgan Stanley downgraded National Vision from Overweight to Equal-Weight

    1/17/23 7:58:03 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results

    Accelerated Initiatives Drive Comparable Store Sales Growth and Improved Profitability Raises Fiscal 2025 Outlook Second quarter 2025 highlights compared to second quarter 2024: Net revenue from continuing operations increased 7.7% to $486.4 million Comparable store sales growth of 6.5% and Adjusted Comparable Store Sales Growth of 5.9% represented the 10th consecutive quarter of positive growth Income from continuing operations of $8.7 million, Diluted EPS from continuing operations of $0.11 Adjusted Operating Income from continuing operations of $23.8 million, up 69.1%, with Adjusted Operating Margin improving to 4.9% from 3.1% Adjusted Diluted EPS from continuing operati

    8/6/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision, Inc. Unveils Bold New Brand Identity as Part of Strategic Transformation

    Brand refresh underscores National Vision's continued business evolution and unwavering commitment to accessible, high-quality eye care and eyewear DULUTH, Ga., Aug. 5, 2025 /PRNewswire/ -- National Vision Holdings, Inc. (NASDAQ:EYE), one of the largest optical retail companies in the United States, unveiled its new corporate brand identity, a major milestone in National Vision's transformation journey. The refreshed branding strengthens National Vision's position as a modern, agile and purpose-driven organization committed to helping people see their best to live their best. Experience the full interactive Multichannel News Release here: https://www.multivu.com/national-vision-holdings/934

    8/5/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Releases Annual Sustainability Report Highlighting 2024 Progress

    National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2024 Sustainability Report, "A World Worth Seeing." The report focuses on the company's performance across its Social, Employees, Environment and Governance (SEE+G) framework, and reflects continued progress against the environmental, social and governance (ESG) issues that matter most to the company's business and stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730016841/en/National Vision released its 2024 Sustainability Report, "A World Worth Seeing." "This past year, our refreshed leadership team made significant stri

    7/30/25 8:21:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships

    Three Students Recognized for Their Insightful Reflections on the Role of Eye Health in Educational and Economic Opportunity National Vision, Inc., one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and commitment to vision equity stood out among this year's applicants for the National Optometric Student Association (NOSA) scholarship program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250729262639/en/Pictured from left to right: Dominica Dzakah; Antoinette Kanayo; Monica Thu Do T

    7/29/25 8:02:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at https://ir.nationalvision.com/. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

    7/23/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Announces Participation in William Blair Growth Stock Conference

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that the Company is scheduled to present at the 45th annual William Blair Growth Stock Conference on Wednesday, June 4, 2025, at 9:20 a.m. Central Time. A live webcast of the presentation can be accessed in the "Investors" section of the Company's website at www.nationalvision.com/investors. The webcast will be archived and available on the website shortly after the event. About National Vision Holdings, Inc. National Vision Holdings, Inc. (NASDAQ:EYE) is one of the largest optical retail companies in the United States with over 1,200 stores in 38 states and Puerto Rico. With a mission of hel

    5/21/25 4:05:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Announces Settlement of 2025 Convertible Senior Notes

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the settlement of the remaining $84.8 million aggregate principal amount of 2.5% unsecured convertible senior notes due May 15, 2025 (the "2025 Convertible Notes"). The settlement was made with $59.8 million from cash on hand and the remaining borrowed under the Company's revolving credit facility. Chris Laden, Chief Financial Officer of National Vision, said, "Our strong cash generation and solid balance sheet support our ongoing approach to a balanced capital allocation strategy, which has included the opportunistic repurchases and the final settlement of our convertible notes. As we look ahe

    5/15/25 4:05:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results

    Successful Execution of New Transformation Initiatives and Cost Reduction Actions Delivered Strong First Quarter First quarter 2025 highlights compared to Q1 2024: Net revenue from continuing operations of $510.3 million, an increase of 5.7% Comparable store sales growth of 4.1% and Adjusted Comparable Store Sales Growth of 5.5% represented the 9th consecutive quarter of positive growth Income from continuing operations of $14.2 million, Diluted EPS from continuing operations of $0.18 Adjusted Operating Income from continuing operations of $41.3 million Adjusted Diluted EPS from continuing operations of $0.34 Raises fiscal 2025 outlook National Vision Holdings, Inc. (NASDAQ:E

    5/7/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Alex Wilkes as CEO

    Reade Fahs to Assume Executive Chairman Position Transition Effective August 1, 2025 National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that its Board of Directors has appointed Alex Wilkes as the Company's next Chief Executive Officer, effective August 1, 2025, and he will join the Company's Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. "National Vision has been on a journey of significant transformation for the past few years, and today I am pleased to announce the next chapter in that tran

    4/29/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings, Inc.

    4/24/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.

    SCHEDULE 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    8/13/25 4:00:04 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form 10-Q filed by National Vision Holdings Inc.

    10-Q - National Vision Holdings, Inc. (0001710155) (Filer)

    8/7/25 8:33:06 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - National Vision Holdings, Inc. (0001710155) (Filer)

    8/6/25 6:07:10 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - National Vision Holdings, Inc. (0001710155) (Filer)

    8/4/25 8:22:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - National Vision Holdings, Inc. (0001710155) (Filer)

    6/23/25 5:04:58 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form 10-Q filed by National Vision Holdings Inc.

    10-Q - National Vision Holdings, Inc. (0001710155) (Filer)

    5/8/25 8:36:28 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - National Vision Holdings, Inc. (0001710155) (Filer)

    5/7/25 6:05:18 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form DEF 14A filed by National Vision Holdings Inc.

    DEF 14A - National Vision Holdings, Inc. (0001710155) (Filer)

    4/29/25 6:22:58 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - National Vision Holdings, Inc. (0001710155) (Filer)

    4/29/25 6:05:32 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.

    SCHEDULE 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    4/28/25 7:50:53 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    11/14/24 12:33:08 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    11/12/24 4:45:48 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    11/4/24 1:18:26 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    9/9/24 11:06:17 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G filed by National Vision Holdings Inc.

    SC 13G - National Vision Holdings, Inc. (0001710155) (Subject)

    2/14/24 3:36:06 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    2/14/24 3:08:01 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    2/13/24 5:09:41 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    2/12/24 6:50:25 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    2/9/24 3:47:48 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

    SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

    2/9/24 9:28:33 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. Leadership Updates

    Live Leadership Updates

    View All

    National Vision, Inc. Unveils Bold New Brand Identity as Part of Strategic Transformation

    Brand refresh underscores National Vision's continued business evolution and unwavering commitment to accessible, high-quality eye care and eyewear DULUTH, Ga., Aug. 5, 2025 /PRNewswire/ -- National Vision Holdings, Inc. (NASDAQ:EYE), one of the largest optical retail companies in the United States, unveiled its new corporate brand identity, a major milestone in National Vision's transformation journey. The refreshed branding strengthens National Vision's position as a modern, agile and purpose-driven organization committed to helping people see their best to live their best. Experience the full interactive Multichannel News Release here: https://www.multivu.com/national-vision-holdings/934

    8/5/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Alex Wilkes as CEO

    Reade Fahs to Assume Executive Chairman Position Transition Effective August 1, 2025 National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that its Board of Directors has appointed Alex Wilkes as the Company's next Chief Executive Officer, effective August 1, 2025, and he will join the Company's Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. "National Vision has been on a journey of significant transformation for the past few years, and today I am pleased to announce the next chapter in that tran

    4/29/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors

    Enters into Cooperation Agreement with Engine Capital National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of two new independent directors, Jim McGrann and Michael Nicholson to its Board of Directors (the "Board"), effective March 17, 2025. Mr. McGrann will serve on the Board's Compensation Committee and Mr. Nicholson will serve on the Board's Audit Committee and Nominating and Corporate Governance Committee. With the addition of Messrs. McGrann and Nicholson, the Board will expand from 9 to 11 members. The Board has also formed an Advisory Committee that will help oversee National Vision's ongoing transformation initiatives with

    3/17/25 4:05:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Christopher Laden as Chief Financial Officer

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of Christopher Laden as Chief Financial Officer, effective March 31, 2025. He will succeed Melissa Rasmussen who, as previously announced, will step down from the Company, effective March 3, 2025. "We are thrilled to welcome Chris to National Vision. He has a proven track record of successfully developing finance organizations into strong cross-functional business partners by focusing on accountability, employee development, and driving efficiencies through the use of digitization. His experience in both the service and optical industries will be instrumental as we move forward

    2/26/25 5:59:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    Mueller Water Products Appoints Melissa Rasmussen as Chief Financial Officer

    ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE:MWA), a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America, announced that it has named Melissa Rasmussen as its Senior Vice President and Chief Financial Officer (CFO) effective March 4, 2025 following a comprehensive search with the support of a leading executive search firm. Ms. Rasmussen is a seasoned financial executive with more than 25 years of experience, most recently serving as the CFO of National Vision, Inc. (NASDAQ:EYE). Ms. Rasmussen joined National Vision in 2019 as the Chief Accounting Officer prior to her pr

    1/16/25 4:09:55 PM ET
    $EYE
    $MWA
    Ophthalmic Goods
    Health Care
    Metal Fabrications
    Industrials

    National Vision Announces the Appointment of Alex Wilkes as President

    Patrick Moore to Retire as Chief Operating Officer National Vision Holdings, Inc. (NASDAQ:EYE) today announced the appointment of Alex Wilkes as National Vision's President, reporting to Reade Fahs, Chief Executive Officer of National Vision, effective August 19, 2024. This follows the Company's announcement on July 1, 2024 of Mark Banner joining the Company as Chief Stores Officer. Wilkes joins National Vision from CooperVision, a global leader in contact lenses, where he served as President of the Americas. Prior to CooperVision, Wilkes spent over a decade at EssilorLuxottica, a leading global eyewear company, in various roles including as Senior Vice President and General Manager of

    8/7/24 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints Caitlin Zulla to Board of Directors

    Adds Healthcare and Financial Expertise to Board National Vision Holdings, Inc. (NASDAQ:EYE), one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, announced today the appointment of Caitlin Zulla to its Board of Directors, effective immediately. Zulla will serve on the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240801515969/en/(Photo: Business Wire) Zulla brings an extensive healthcare background, with expertise in primary care and specialty care services. She currently serves as Chief Executive Officer of Optum Health East, part of UnitedHealth G

    8/1/24 4:30:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Welcomes Mark Banner as New Chief Stores Officer

    National Vision Holdings, Inc. (NASDAQ:EYE) is pleased to announce the appointment of Mark Banner as the company's new Chief Stores Officer, effective July 8, 2024. Banner is a mission-driven specialty retailer who joins the company after a distinguished seven-year tenure at Sleep Number. Most recently, he served as senior vice president of retail and real estate. His extensive experience encompasses leading teams in sales, sales operations, digital, promotion and real estate. Before Sleep Number, Banner dedicated 18 years to Signet Jewelers, the world's largest specialty retailer jeweler. He began his career at Signet as a store manager and rose through the ranks to district manager, v

    7/1/24 4:15:00 PM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Puts Pediatric Eye Care in Focus for 2023-2024 Scholarship Program

    $7,500 to be Awarded to Third- and Fourth-Year Optometry Students in Program's Ninth Year National Vision, Inc., the nation's second largest optical retailer providing quality, affordable eye care and eyewear, announced today that its annual scholarship program is open for entries, providing eligible optometry students with a chance to win up to $7,500. This year's scholarship program challenges students to share their perspective on "Increasing Access to Eye Care for Children." Third- and fourth-year optometry students may submit written or video essays on the topic, offering their take on why proper vision care is important for all children. Entrants are also challenged to address how

    10/19/23 8:30:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Appoints New Chief Marketing Officer

    Joe VanDette Brings Two Decades of Transformative Marketing Experience to the Company National Vision Holdings, Inc. (NASDAQ:EYE), announced today that Joe VanDette has joined the company as Chief Marketing Officer, reporting to Chief Executive Officer Reade Fahs. VanDette will be responsible for leading the organization's Marketing function including strategic brand management, CRM, advertising and media, digital marketing, e-commerce and research/insights. "Joe is a talented individual with an impressive track record of using data driven customer-centric approaches to drive business expansion," said Reade Fahs, Chief Executive Officer of National Vision. "We expect he will fit in well w

    4/11/22 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings Inc. Financials

    Live finance-specific insights

    View All

    National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results

    Accelerated Initiatives Drive Comparable Store Sales Growth and Improved Profitability Raises Fiscal 2025 Outlook Second quarter 2025 highlights compared to second quarter 2024: Net revenue from continuing operations increased 7.7% to $486.4 million Comparable store sales growth of 6.5% and Adjusted Comparable Store Sales Growth of 5.9% represented the 10th consecutive quarter of positive growth Income from continuing operations of $8.7 million, Diluted EPS from continuing operations of $0.11 Adjusted Operating Income from continuing operations of $23.8 million, up 69.1%, with Adjusted Operating Margin improving to 4.9% from 3.1% Adjusted Diluted EPS from continuing operati

    8/6/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at https://ir.nationalvision.com/. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

    7/23/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results

    Successful Execution of New Transformation Initiatives and Cost Reduction Actions Delivered Strong First Quarter First quarter 2025 highlights compared to Q1 2024: Net revenue from continuing operations of $510.3 million, an increase of 5.7% Comparable store sales growth of 4.1% and Adjusted Comparable Store Sales Growth of 5.5% represented the 9th consecutive quarter of positive growth Income from continuing operations of $14.2 million, Diluted EPS from continuing operations of $0.18 Adjusted Operating Income from continuing operations of $41.3 million Adjusted Diluted EPS from continuing operations of $0.34 Raises fiscal 2025 outlook National Vision Holdings, Inc. (NASDAQ:E

    5/7/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings, Inc.

    4/24/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2024 Financial Results

    Strong Fourth Quarter Results Reflect Successful Execution on Store-Level Transformation Initiatives Introduced Targeted Initiatives to Broaden Appeal and Expand Customer Base Actions Taken to Reduce Costs and Strengthen Profitability Fourth quarter 2024 highlights: Net revenue from continuing operations of $437.3 million, an increase of 3.9% as compared to Q4 2023 Comparable store sales growth of 2.6% and Adjusted Comparable Store Sales Growth of 1.5% as compared to Q4 2023 Net loss from continuing operations of $(29.4) million, Diluted EPS from continuing operations of $(0.37) Adjusted Operating Income from continuing operations increased to $3.2 million from $(2.7) mill

    2/26/25 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its fourth quarter and fiscal 2024 financial results before the market opens on February 26, 2025 and will host a conference call at 8:00 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdin

    2/12/25 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Reports Third Quarter 2024 Financial Results

    Results Reflect Ongoing Strength in Managed Care with Growth in America's Best as Transformation Initiatives Progress Third quarter 2024 highlights compared to Q3 2023: Net revenue from continuing operations of $451.5 million, an increase of 2.9% Comparable store sales growth of 1.4% and Adjusted Comparable Store Sales Growth of 0.9% Net loss from continuing operations of $(8.4) million, Diluted EPS from continuing operations of $(0.11) Adjusted Operating Income from continuing operations of $14.3 million Adjusted Diluted EPS from continuing operations of $0.12 Reaffirms fiscal 2024 outlook for key metrics, updates capital expenditure expectations National Vision Holdings, In

    11/6/24 6:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces Third Quarter 2024 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its third quarter 2024 financial results before the market opens on Wednesday, November 6, 2024 and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

    10/23/24 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Reports Second Quarter 2024 Financial Results

    Announces New Actions to Accelerate Transformation Second quarter 2024 highlights(1) compared to Q2 2023: Net revenue from continuing operations of $451.7 million, an increase of 4.6% Comparable store sales growth of 2.2% and Adjusted Comparable Store Sales Growth of 2.4% Net loss from continuing operations of $(1.0) million, Diluted EPS from continuing operations of $(0.01) Adjusted Operating Income from continuing operations of $14.1 million Adjusted Diluted EPS from continuing operations of $0.15 Discontinued Operations resulted in net revenue of $53.5 million, Net loss, net of tax, of $(2.1) million, Diluted EPS of $(0.03) and Adjusted Diluted EPS of $0.00 Revises

    8/7/24 6:01:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call

    National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024 and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

    7/24/24 8:00:00 AM ET
    $EYE
    Ophthalmic Goods
    Health Care